Pharming Group NV Strategic Asset Allocation Index
Pharming Group NV strategic asset allocation index. Pharming Group NV (PHARM) has a Strategic Asset Allocation Index of 2.5% as of September 2025. Strategic assets (PP&E of €- plus long-term investments of €6.67 Million) total €6.67 Million, measured against net assets of €264.64 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See PHARM net asset quality index to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
Strategic Asset Allocation Index of Pharming Group NV (2013–2024)
Strategic asset allocation index of Pharming Group NV from 2013 to 2024. This chart shows how Pharming Group NV's Strategic Asset Allocation Index has evolved across 12 annual periods from 2013 to 2024. As of September 2025, the index stands at 2.5%, representing strategic assets of €6.67 Million against net assets of €264.64 Million EUR. Check tangible equity quality of Pharming Group NV to evaluate the tangible quality of the company's equity base.
Pharming Group NV Strategic Asset Allocation Index by Year (2013–2024)
Pharming Group NV strategic asset allocation index by year from 2013 to 2024. The table below presents the year-by-year Strategic Asset Allocation Index for Pharming Group NV from 2013 to 2024, covering 12 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see PHARM market cap overview.
| Year | SAAI | Strategic Assets (EUR) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2024 | 2.0% | €4.23 Million | €- | €4.23 Million | €214.16 Million | ▼ -3.3 pp |
| 2023 | 5.3% | €10.40 Million | €- | €10.40 Million | €198.05 Million | ▼ -18.6 pp |
| 2022 | 23.9% | €48.88 Million | €39.15 Million | €9.73 Million | €204.64 Million | ▲ +2.1 pp |
| 2021 | 21.8% | €41.95 Million | €33.16 Million | €8.79 Million | €192.72 Million | ▲ +6.8 pp |
| 2020 | 14.9% | €27.45 Million | €21.65 Million | €5.80 Million | €183.73 Million | ▼ -3.5 pp |
| 2019 | 18.4% | €21.60 Million | €16.30 Million | €5.31 Million | €117.26 Million | ▲ +6.5 pp |
| 2018 | 11.9% | €8.40 Million | €8.40 Million | €- | €70.64 Million | ▼ -24.6 pp |
| 2017 | 36.5% | €8.23 Million | €8.23 Million | €- | €22.56 Million | ▲ +15.6 pp |
| 2016 | 20.9% | €6.04 Million | €6.04 Million | €- | €28.89 Million | ▼ -0.8 pp |
| 2015 | 21.7% | €5.66 Million | €5.66 Million | €- | €26.06 Million | ▲ +6.3 pp |
| 2014 | 15.4% | €5.60 Million | €5.60 Million | €- | €36.29 Million | ▼ -74.6 pp |
| 2013 | 90.0% | €6.23 Million | €6.23 Million | €- | €6.92 Million | — |